# Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic Steroids

> **NCT05946135** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 42 (actual)

## Conditions studied

- Patients on Treatment With Systemic Steroids

## Interventions

- **DRUG:** Lansoprazole
- **DRUG:** Fexuprazan Hydrochloride

## Key facts

- **NCT ID:** NCT05946135
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-07
- **Primary completion:** 2025-09-08
- **Final completion:** 2025-09-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946135, "Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic Steroids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05946135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*